Simcere Pharmaceutical Posts H1 Revenue Of RMB 3,585 Million

Reuters
Aug 21, 2025
Aug 21 (Reuters) - Simcere Pharmaceutical Group Ltd <2096.HK>::
*H1 REVENUE RMB 3,585 MILLION
*H1 NET INCOME RMB 604 MILLION
*H1 BASIC EPS RMB 0.25
*Further company coverage: 2096.HK
* ((Reuters.Briefs@thomsonreuters.com;))

((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))
Source Date/Time = 21-AUG-202513:07:02.657 GMT

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10